Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2023 10:26 ET | Source: Zenas BioPharma

Zenas BioPharma Fecha Acordo de Licenciamento e Colaboração Estratégica com a Bristol Myers Squibb para Desenvolvimento e Comercialização do Novo Anticorpo Bifuncional Obexelimab no Japão, Coreia do Sul, Taiwan, Cingapura, Hong Kong e Austrália

Colaboração promove a visão da Zenas de oferecer medicamentos inovadores baseados em imunologia para pacientes em todo o mundo, aproveitando a experiência de longa data da Bristol Myers Squibb com...
September 05, 2023 10:26 ET | Source: Zenas BioPharma

Zenas BioPharma anuncia acuerdo estratégico de licenciamiento y colaboración con Bristol Myers Squibb para desarrollo y comercialización del nuevo anticuerpo bifuncional Obexelimab en Japón, Corea del Sur, Taiwán, Singapur, Hong Kong y Australia

La colaboración amplía la visión de Zenas de llevar fármacos innovadores basados en inmunología a pacientes de todo el mundo utilizando la experiencia de larga data de Bristol Myers Squibb en...
September 05, 2023 10:26 ET | Source: Zenas BioPharma

Zenas BioPharma ประกาศข้อตกลงว่าด้วยใบอนุญาตเชิงกลยุทธ์และความร่วมมือกับ Bristol Myers Squibb เพื่อพัฒนาและจำหน่าย Novel Bi-Functional Antibody Obexelimab ในญี่ปุ่น เกาหลีใต้ ไต้หวัน สิงคโปร์ ฮ่องกง และออสเตรเลีย

ความร่วมมือดังกล่าวช่วยส่งเสริมวิสัยทัศน์ของ Zenas ที่จะนำยาภูมิคุ้มกันวิทยาที่ใช้นวัตกรรมที่ทันสมัยไปสู่ผู้ป่วยทั่วโลก โดยใช้ความเชี่ยวชาญที่มีมายาวนานของ Bristol Myers Squibb...
September 05, 2023 07:00 ET | Source: MacroGenics, Inc.

MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

ROCKVILLE, MD, Sept. 05, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
September 05, 2023 06:00 ET | Source: Zenas BioPharma

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated...
September 01, 2023 17:20 ET | Source: Somai Pharmaceuticals

SOMAÍ Pharmaceuticals ontvangt EU-GMP-certificering en haalt € 5 miljoen op

LISBON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (het "Bedrijf" of "SOMAÍ"), de grootste Europese fabrikant van farmaceutische cannabisproducten, is verheugd...
September 01, 2023 17:20 ET | Source: Somai Pharmaceuticals

SOMAÍ Pharmaceuticals reçoit un Certificat de bonnes pratiques de fabrication (BPF) de l'Union européenne et lève 5 millions d'euros

LISBONNE, 01 sept. 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (la « Société » ou « SOMAÍ »), le plus grand fabricant de produits à base de cannabis pharmaceutique d'Europe, a le...
September 01, 2023 17:20 ET | Source: Somai Pharmaceuticals

SOMAÍ Pharmaceuticals erhält EU-GMP-Zertifizierung und 5 Mio. Euro frisches Kapital

LISSABON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (das „Unternehmen“ oder „SOMAÍ“), der größte europäische Hersteller pharmazeutischer Cannabisprodukte,...
September 01, 2023 17:20 ET | Source: Somai Pharmaceuticals

SOMAÍ Pharmaceuticals ottiene la certificazione EU-GMP e raccoglie 5 milioni di euro

LISBONA, Portogallo, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (la "Società" o "SOMAÍ"), il più grande produttore europeo di prodotti farmaceutici a base di cannabis, è...
September 01, 2023 17:20 ET | Source: Somai Pharmaceuticals

SOMAÍ Pharmaceuticals recibe el certificado EU-GMP y recauda 5 millones de euros

LISBOA, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (la «Empresa» o «SOMAÍ»), el mayor fabricante europeo de productos farmacéuticos a base de cannabis, se...